Novo Nordisk A/S

NOV XETRA / Francfort Healthcare & Biotech Monde
39.73 €
0.69 %

Novo Nordisk A/S is a global pharmaceutical company focused on the research, development, and marketing of treatments for diabetes and other serious hormonal diseases.

diabetes pharmaceutical